Inventor · disambiguated record
Robert A. Baughman
Also filed as: BAUGHMAN ROBERT A
12 granted patents·14 pending applications·233 citations·filing 2008–2024
90Inventor score
Top patents by PatentIndex Score
26 records- 0197US8372804B2Delivery of active agentsMANNKIND CORP·Filed 2008·Granted Feb 12, 2013·60 cites·21 claims
- 0296US8377869B2Method of preventing adverse effects by GLP-1MANNKIND CORP·Filed 2008·Granted Feb 19, 2013·57 cites·20 claims
- 0396US8119593B2Method of treating diabetes type 2 by metformin and an ultrarapid acting insulinRICHARDSON PETER·Filed 2009·Granted Feb 21, 2012·110 cites·33 claims
- 0489US2024197836A1Method of treating diabetes type 2 by administering ultrarapid acting insulinMANNKIND CORP·Filed 2024·Application pending·0 cites
- 0586US2024197627A1Delivery of active agentsMANNKIND CORP·Filed 2024·Application pending·0 cites
- 0681US11304992B2Inhalable dry powder pharmaceutical compositionMANNKIND CORP·Filed 2019·Granted Apr 19, 2022·1 cites·6 claims
- 0781US2022362147A1Delivery of Active AgentsMANNKIND CORP·Filed 2022·Application pending·0 cites
- 0880US11110151B2Composition and method for reducing hypoglycemia events in diabetes treatmentMANNKIND CORP·Filed 2019·Granted Sep 7, 2021·1 cites·12 claims
- 0977US2022387593A1Method of preventing adverse effects by glp-1MANNKIND CORP·Filed 2022·Application pending·0 cites
- 1076US11998591B2Method of treating diabetes type 2 by administering ultrarapid acting insulinMANNKIND CORP·Filed 2020·Granted Jun 4, 2024·0 cites·11 claims
- 1176US2024342251A1Method of treating hypoglycemia events in diabetes treatmentMANNKIND CORP·Filed 2024·Application pending·0 cites
- 1275US8623817B2Method of treating diabetes type 2 by administering ultrarapid acting insulinRICHARDSON PETER·Filed 2012·Granted Jan 7, 2014·1 cites·20 claims
- 1373US8921311B2Method for treating hyperglycemiaCOSTELLO DONALD·Filed 2011·Granted Dec 30, 2014·1 cites·28 claims
- 1471US11980656B2Method of treating hypoglycemia events in diabetes treatmentMANNKIND CORP·Filed 2021·Granted May 14, 2024·0 cites·6 claims
- 1570US10857207B2Method of treating diabetes type 2 by administering ultrarapid acting insulinMANNKIND CORP·Filed 2018·Granted Dec 8, 2020·0 cites·5 claims
- 1668US2020146981A1Delivery of active agentsMANNKIND CORP·Filed 2020·Application pending·0 cites
- 1767US9943571B2Use of ultrarapid acting insulinMANNKIND CORP·Filed 2013·Granted Apr 17, 2018·0 cites·23 claims
- 1867US9078866B2Method for treating hyperglycemia with GLP-1COSTELLO DONALD·Filed 2010·Granted Jul 14, 2015·2 cites·12 claims
- 1966US2019167580A1Delivery of Active AgentsMANNKIND CORP·Filed 2019·Application pending·0 cites
- 2064US2020147219A1Method of preventing adverse effects by glp-1MANNKIND CORP·Filed 2020·Application pending·0 cites
- 2163US2015080298A1Method for treating hyperglycemiaMANNKIND CORP·Filed 2014·Application pending·0 cites
- 2261US2013118491A1Delivery of Active AgentsMANNKIND CORP·Filed 2013·Application pending·0 cites
- 2359US2023293436A1Inhalable dry powder pharmaceutical compositionMANNKIND CORP·Filed 2022·Application pending·0 cites
- 2456US2013125886A1Method of preventing adverse effects by glp-1RICHARDSON PETER·Filed 2013·Application pending·0 cites
- 2555US2017304404A1Method for treating hyperglycemia with glp-1MANNKIND CORP·Filed 2017·Application pending·0 cites
- 2650US2015283213A1Method for treating hyperglycemia with glp-1MANNKIND CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert A. Baughman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →